Grants and Contracts Details
Description
HUMAN CLINICAL TRIAL - CONFIDENTIAL
To assess the safety and tolerability of the daily oral administration of
nilotinib (150-300mg once daily) in moderate/advanced and early/de novo
PD participants.
Status | Finished |
---|---|
Effective start/end date | 11/7/17 → 9/17/19 |
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.